Breakthrough Cancer/Ludwig Institute for Cancer ResearchLondon (May 1st) -- For several years, scientists have attempted to identify gene expression changes, using microarrays or 'DNA chips', in order to understand and predict breast cancer onset, progression, and clinical outcome. Although important insights into breast cancer have been drawn from determining the expression 'profiles' of thousands of genes in tumors, the interpretation of experimental results has been complicated by the absence of knowledge about the gene expression in 'normal', non-cancerous, breast cells. However in a paper published today in the journal Cancer Research, a team of scientists from The Breakthrough Toby Robins Breast Cancer Research Centre at The Institute of Cancer Research (ICR) in London, and the Breast Cancer Laboratory of Ludwig Institute for Cancer Research (LICR) and University College London report that they have now elucidated the expression profiles of over 6000 genes in the two primary types of normal breast cells.
The majority of breast cancers originate in an internal structure of the breast, the terminal duct-lobular unit, which is comprised of two different types of cell; the inner 'luminal' cells, potential milk-secreting cells, in which cancerous genetic changes occur; and the surrounding basal layer of contractile 'myoepithelial' cells. The LICR/Breakthrough team separated and purified the two cell types from material from breast reduction surgery, and showed that the cell types have distinct and quite different gene expression profiles.
"The problem is that the vast majority of breast cancer experiments have used tumor samples because that was usually the only material available," explains LICR's Dr. A. Munro Neville, one of the senior authors of the study. "But tumors actually have different mixtures of normal luminal cells, normal myoepithelial cells, and cancer cells. Now we not only know that these cells have very different gene expression ch
'"/>
Contact: Sarah L. White, Ph.D.
swhite@licr.org
212-450-1543
Ludwig Institute for Cancer Research
1-May-2004
Page: 1 2 3 Related biology news :1.
Setting the evolutionary record straight2.
Setting the stage for limb development3.
Setting the real bottom line: Dr. David Suzuki to speak at ESA annual meeting4.
A novel, safer strategy for regulating gene expression5.
Gene expression in liver tumors and patient prognosis6.
Analysis of gene expression in lymphoid cells can determine lymphoma cancer7.
Jefferson scientists find gene expression pattern may predict behavior of leukemia8.
Outcome for acute lymphoblastic leukemia linked to gene expression patterns9.
Microarrays, key genome expression trackers, work better when probes are sequence-verified10.
Gene expression patterns may help predict risk and progression of prostate cancer11.
Altered expression of key developmental genes underlies evolution of butterfly wing patterns